MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
0.6519
-0.0169
-2.53%
After Hours: 0.6512 -0.0007 -0.11% 19:52 01/02 EST
OPEN
0.6595
PREV CLOSE
0.6688
HIGH
0.6659
LOW
0.6420
VOLUME
240.68K
TURNOVER
--
52 WEEK HIGH
2.280
52 WEEK LOW
0.2813
MARKET CAP
29.06M
P/E (TTM)
-0.5342
1D
5D
1M
3M
1Y
5Y
1D
Harvard Bioscience Inc. Files Initial Beneficial Ownership Statement for Director William Snider
Reuters · 12/31/2025 01:47
Weekly Report: what happened at HBIO last week (1222-1226)?
Weekly Report · 12/29/2025 10:16
Weekly Report: what happened at HBIO last week (1215-1219)?
Weekly Report · 12/22/2025 10:15
Harvard Bioscience Secures $40M Loan Agreement
TipRanks · 12/17/2025 12:54
Harvard Bioscience enters agreement with BroadOak Capital Partners
TipRanks · 12/17/2025 12:40
Harvard Bioscience Strikes Agreement With BroadOak Capital Partners To Offer $40M Credit Facility Of Three Term Loans
Benzinga · 12/17/2025 12:37
*Harvard Bioscience; BroadOak Partner Bill Snider to Join Bd of Directors >HBIO
Dow Jones · 12/17/2025 12:33
*Harvard Bioscience: To Form Advisory Bd on Growth and Operating Opportunities >HBIO
Dow Jones · 12/17/2025 12:33
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.